Neary R H, Gowland E
Department of Chemical Pathology, University Hospital of South Manchester, West Didsbury, UK.
Clin Chim Acta. 1988 Feb 15;171(2-3):239-45. doi: 10.1016/0009-8981(88)90149-0.
Free apolipoprotein A-1 (free A-1) was measured by quantitative crossed immunoelectrophoresis in 43 patients with severe chronic renal failure. The free A-1 concentrations in these patients were higher than in 28 healthy subjects irrespective of whether they where receiving haemodialysis or conservative treatment. A close correlation was found between serum concentration of free A-1 and creatinine in patients with varying degrees of chronic renal failure (r = 0.717, p less than 0.001). In three patients who received renal transplants serial measurements of free A-1 showed a decrease to normal levels within two days post-operatively. These findings suggest a relationship between the serum concentration of free A-1 and glomerular filtration. In conjunction with the report implicating the kidney as the major site of catabolism of Apo A-1 in the rat, these results suggest a similar role for the kidney in man. No evidence has been found linking free A-1 with hypertriglyceridaemia in patients with renal failure as has been suggested previously.
采用定量交叉免疫电泳法对43例严重慢性肾衰竭患者的游离载脂蛋白A-1(游离A-1)进行了检测。无论这些患者是接受血液透析还是保守治疗,其游离A-1浓度均高于28名健康受试者。在不同程度慢性肾衰竭患者中,游离A-1血清浓度与肌酐之间存在密切相关性(r = 0.717,p<0.001)。在3例接受肾移植的患者中,对游离A-1进行的系列检测显示,术后两天内其水平降至正常。这些发现提示游离A-1血清浓度与肾小球滤过之间存在关联。结合有关大鼠体内载脂蛋白A-1主要分解代谢部位为肾脏的报道,这些结果提示人类肾脏也发挥类似作用。此前曾有研究表明肾衰竭患者的游离A-1与高甘油三酯血症有关,但本研究未发现相关证据。